Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: An excess cancer incidence of 20-25% has been identified among persons with diabetes, most of whom have type 2 diabetes. We aimed to describe the association between type 1 diabetes and cancer incidence. METHODS: Persons with type 1 diabetes were identified from five nationwide diabetes registers: Australia (2000-2008), Denmark (1995-2014), Finland (1972-2012), Scotland (1995-2012) and Sweden (1987-2012). Linkage to national cancer registries provided the numbers of incident cancers in people with type 1 diabetes and in the general population. We used Poisson models with adjustment for age and date of follow up to estimate hazard ratios for total and site-specific cancers. RESULTS: A total of 9,149 cancers occurred among persons with type 1 diabetes in 3.9 million person-years. The median age at cancer diagnosis was 51.1 years (interquartile range 43.5-59.5). The hazard ratios (HRs) (95% CIs) associated with type 1 diabetes for all cancers combined were 1.01 (0.98, 1.04) among men and 1.07 (1.04, 1.10) among women. HRs were increased for cancer of the stomach (men, HR 1.23 [1.04, 1.46]; women, HR 1.78 [1.49, 2.13]), liver (men, HR 2.00 [1.67, 2.40]; women, HR 1.55 [1.14, 2.10]), pancreas (men, HR 1.53 [1.30, 1.79]; women, HR 1.25 [1.02,1.53]), endometrium (HR 1.42 [1.27, 1.58]) and kidney (men, HR 1.30 [1.12, 1.49]; women, HR 1.47 [1.23, 1.77]). Reduced HRs were found for cancer of the prostate (HR 0.56 [0.51, 0.61]) and breast (HR 0.90 [0.85, 0.94]). HRs declined with increasing diabetes duration. CONCLUSION: Type 1 diabetes was associated with differences in the risk of several common cancers; the strength of these associations varied with the duration of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Variably increased risk has been reported for cancers of the breast (postmenopausal) endometrium ovary gall bladder, stomach and esophagus, kidney, thyroid (papillary, follicular, and anaplastic but not medullary), colon, bladder, and pancreas.1733,1734,1739–1752”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1746]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · cited 1×
“HR estimates for site-specific cancers were highest for cancer types in which obesity is an established risk factor, namely stomach, colorectal, kidney, endometrial and pancreatic cancers [21].”
BackgroundWorldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,288 · cited 1×
“The worldwide incidence rates of thyroid cancer have increased steeply in recent decades [30, 31], partly due to enhanced detection through the use of more sensitive diagnostic equipment.”
BackgroundType-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105 · cited 1×
“For example, it is well established that pancreatic cancer can induce diabetes [35].”
BackgroundVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875 · cited 1×
“Previous studies assessing the influence of type 2 or unspecified diabetes on breast cancer have displayed a similar or elevated risk compared with the general population, although these findings are largely limited to post-menopausal women [28].”
ResultType 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782 · cited 1×
“were previously shown to lead to an increased risk of prostate cancer [33], while hyperglycaemia has also been shown to”
BackgroundWideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627 · cited 1×
“Although this definition of type 1 diabetes is not strictly comparable with ours, the result is consistent with our findings [19].”
Result
Research works printed but not linked: 1
- Harrell JFE Regression modeling strategies 2006 New York Springer
Cited by
The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
Self-citationThe Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
“Some studies have also suggested that the increased risk of cancer diagnosis is greatest within the first year following onset of DM1, indicating a possible detection bias (78).”
Metformin: Is it a drug for all reasons and diseases?
Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 275
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Shlomai, G., Neel, B., LeRoith, D., & Gallagher, E. J. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4044 · Cited by 236
“However, cancer incidence was increased for stomach, liver, pancreas, endometrium, and kidney cancers and was reduced for prostate cancer.(7) These cancers were mostly detected within the first year after diagnosis of T1DM, which suggests a detection bias in those with newly diagnosed T1DM and that long-term hyperglyc…”
BackgroundInsulin, insulin receptors, and cancer
Vigneri, R., Goldfine, I. D., & Frittitta, L. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0508-7 · Cited by 216
“Also type I diabetes, characterized by endogenous insulin deficiency but treated with exogenous either insulin or insulin analogs, often at a dosage that exceeds the normal insulin levels, is associated with increased cancer risk [55].”
BackgroundInfluentialOhkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188
“Data on all-site cancer were available from 47 studies, involving 121 cohorts, 19,239,302 individuals (not counting one study [25] that did not state the total number of participants), and 1,082,592 events (not counting one study [65] that did not state the total number of cancer events).”
BackgroundInfluentialDiabetes and Cancer: Risk, Challenges, Management and Outcomes
Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Suh, S., & Kim, K.-W. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0177 · Cited by 185
Insulin Resistance and Cancer: In Search for a Causal Link
Chiefari, E., Mirabelli, M., La Vignera, S., Tanyolaç, S., Foti, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 170
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
Zhu, B., & Qu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.800995 · Cited by 165
“But, there was evidence of heterogeneity in risk of some cancers by country, and T1DM duration (7).”
BackgroundInfluentialDiabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’
Cignarelli, A., Genchi, V. A., Caruso, I., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.002 · Cited by 161
Simon, T. G., King, L. Y., Chong, D. Q., Nguyen, L. H., Ma, Y., VoPham, T., Giovannucci, E. L., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., et al. (2018) · Hepatology · doi:10.1002/hep.29660 · Cited by 160
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection
Moscicki, A., Flowers, L., Huchko, M. J., Long, M. E., MacLaughlin, K. L., Murphy, J., Spiryda, L. B., & Gold, M. A. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000468 · Cited by 158
“Carstensen et al.(115) reported on the incidence of CC among 9,149 cancers found in women with type 1 DM compared with the general population in Australia, Denmark, Finland, Sweden, and Scotland.”
BackgroundRuze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 125
“Many epidemiological studies have concluded that type 1 DM (T1DM) and type 2 DM (T2DM) increase the risk of PC in both sexes.(8,91) Epidemiological data have also showed that hyperglycemia in the first few years, commonly known as newonset DM, induces a higher PC risk than long-standing DM,(92) whereas studies on LSL-…”
BackgroundBallotari, P., Vicentini, M., Manicardi, V., Gallo, M., Ranieri, S. C., Greci, M., & Rossi, P. G. (2017) · BMC Cancer · doi:10.1186/s12885-017-3696-4 · Cited by 120
“There is considerable evidence linking diabetes and cancer incidence [2, 3] and many epidemiological studies have found association between diabetes and several types of cancer, such as liver, pancreas, endometrium, kidney, breast, prostate, bladder, and colorectal cancer [4–11].”
Bjornsdottir, H. H., Rawshani, A., Rawshani, A., Franzén, S., Svensson, A.-M., Sattar, N., & Gudbjörnsdottir, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-73668-y · Cited by 110
Self-citationType 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
Sona, M. F., Myung, S., Park, K., & Galsuren, J. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy047 · Cited by 112
Harding, J. L., Weber, M. B., & Shaw, J. E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch3 · Cited by 104
Self-citationAutoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis
Song, M., Latorre, G., Danisa Ivanovic-Zuvic, S., Camargo, M. C., & Rabkin, C. S. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.151 · Cited by 97
Insights into the relationships between diabetes, prediabetes, and cancer
Scappaticcio, L., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-1216-y · Cited by 95
“with type 1 diabetes also determines an increased risk of mortality is at present uncertain, so that future studies are needed to verify such issue [40].”
BackgroundScreening for Coronary Artery Disease in Cancer Survivors
Velusamy, R., Nolan, M. T., Murphy, A. J., Thavendiranathan, P., & Marwick, T. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.007 · Cited by 90
“and the incidence of the genitourinary and gastrointestinal cancer is significantly increased for women.(44,46,47) With regard to type 2 diabetes mellitus, studies have shown associations between type 2 diabetes mellitus and risks of gastrointestinal, lung, genitourinary, and breast cancer.”
BackgroundSystematic review of modifiable risk factors for kidney cancer
Al-Bayati, O., Hasan, A., Pruthi, D. K., Kaushik, D., & Liss, M. A. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.12.008 · Cited by 88
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Menini, S., Iacobini, C., Vitale, M., Pesce, C. M., & Pugliese, G. (2021) · Cancers · doi:10.3390/cancers13020313 · Cited by 87
Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study
Khan, U. A., Fallah, M., Sundquist, K., Sundquist, J., Brenner, H., & Kharazmi, E. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003431 · Cited by 83
“This suggests that the association between diabetes and CRC is not purely dependent on lifestyle factors and therefore, irrespective of type, is an ideal candidate for risk-adapted CRC screening [30].”
BackgroundMechanistic Links between Obesity, Insulin, and Cancer
Perry, R. J., & Shulman, G. I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.003 · Cited by 84
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 79
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 77
“Diabetic patients with PDAC frequently have larger tumors, reduced median survival [39], and higher mortality [40, 41].”
BackgroundBut, A., Bruin, M. L. D., Bazelier, M. T., Hjellvik, V., Andersen, M. T., Auvinen, A. P., Starup‐Linde, J., Schmidt, M. K., Furu, K., de Vries, F., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4312-5 · Cited by 77
“Diabetes is associated with an increased risk for certain cancers [3] and the pattern and magnitude of the excess risk are generally similar for type 1 and 2 diabetes [4, 5].”
Gallo, M., Muscogiuri, G., Felicetti, F. C., Faggiano, A., Trimarchi, F., Arvat, E., Vigneri, R., & Colao, A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.013 · Cited by 76
Rentsch, C. T., Farmer, R. E., Eastwood, S. V., Mathur, R., Garfield, V., Farmaki, A., Bhaskaran, K., Chaturvedi, N., & Smeeth, L. L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001600 · Cited by 66
Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis
Su, Y., Luo, Y., Zhang, P., Lin, H., Pu, W., Zhang, H., Wang, H., Hao, Y., Xiao, Y., Zhang, X., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.010 · Cited by 66
Guo, J., Liu, C., Pan, J., & Yang, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109866 · Cited by 64
Lin, Z., Sui, X., Jiao, W., Chen, C., Zhang, X., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.953874 · Cited by 64
“A study on 9,000 cancer patients in type 1 diabetes has found that the incidence of UCEC is significantly higher in the general population (Carstensen et al., 2016).”
BackgroundAssociations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 61
“Observations performed for non-sex-specific cancers showed that the estimated hazard ratio (HR) for overall cancers was 1.01 among men and 1.07 among women in comparison with the general population [49].”
BackgroundInfluentialSlowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives
Nishimura, A., Matsumura, K., Kikuno, S., Nagasawa, K., Okubo, M., Mori, Y., & Kobayashi, T. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s191007 · Cited by 56
Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells
Kosowska, A., Gallego-Colon, E., Garczorz, W., Kłych-Ratuszny, A., Aghdam, M. R. F., Woz´niak, M., Witek, A., Wróblewska-Czech, A., Cygal, A., Wojnar, J., et al. (2017) · Endocrine Connections · doi:10.1530/ec-17-0294 · Cited by 45
Changing patterns of sexually transmitted infections in India.
Sharma, V., & Khandpur, S. (2004) · PubMed · Cited by 47
Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies
Dong, W., Zhang, D.-L., Wang, Z., Lv, C.-Z., Zhang, P., & Zhang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971213 · Cited by 47
Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links
Wang, Y., Zeng, X., Tan, J., Xu, Y., & Yi, C. (2022) · Medicine · doi:10.1097/md.0000000000030299 · Cited by 46
“58).[12] In addition, Except for increased incidence of EC, DM may be an independent risk factor for EC mortality.”
BackgroundFucic, A., Guszak, V., & Mantovani, A. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.06.044 · Cited by 45
Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study
Xiong, F., Wang, J., Nierenberg, J. L., Blarigan, E. L. V., Kenfield, S. A., Chan, J. M., Schmajuk, G., Huang, C., & Graff, R. E. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02345-4 · Cited by 43
Wang, H., Zhong, L., Xu, B., Chen, M., & Huang, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040137 · Cited by 43
TINSLEY, L. J., Kupelian, V. A., D’Eon, S., POBER, D. M., Sun, J. K., King, G. L., & Keenan, H. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00589 · Cited by 41
Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
Capobianco, E. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0155-4 · Cited by 39
Can type 1 diabetes be an unexpected complication of obesity?
Oboza, P., Ogarek, N., Olszanecka‐Glinianowicz, M., & Kocełak, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1121303 · Cited by 38
“In addition, a five-country study of 9,000 cancers in patients with T1D showed a 15% higher risk of cancer in men and 17% in women with T1D (85).”
BackgroundZádori, N., Szakó, L., Váncsa, S., Vörhendi, N., Oštarijaš, E., Kiss, S., Frim, L., Hegyi, P. J., & Czimmer, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750533 · Cited by 37
Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus
Herms, A., Colom, B., Piedrafita, G., Kalogeropoulou, A., Banerjee, U., King, C., Abby, E., Murai, K., Caseda, I., Fernández‐Antorán, D., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01891-8 · Cited by 37
Mao, D., Lau, E. S. H., Wu, H., Yang, A., Shi, M., Fan, B., Tam, C. H. T., Chow, E., Kong, A. P. S., Ronald, C. W., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100315 · Cited by 37
Sund, R., Gissler, M., Hakulinen, T. R., & Rosén, M. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_5 · Cited by 36
Self-citationDiabetes and Cancer: A Twisted Bond
Stan, M. C., & Paul, D. (2024) · Oncology Reviews · doi:10.3389/or.2024.1354549 · Cited by 35
“Melanoma, Hodgkin ’ s lymphoma, and breast cancer were notably less common in women with type 1 diabetes [74, 77].”
BackgroundResultInfluentialCatarinella, D., Melzi, R., Mercalli, A., Magistretti, P., Tentori, S., Gremizzi, C., Paloschi, V., COBELLI, F. D., Esposto, G., Costa, S., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00341-3 · Cited by 35
Li, C. M., & Chen, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.664305 · Cited by 35
“Type 1 diabetes can be associated with cancer of the endometrium, kidney, liver, pancreas, and stomach (Carstensen et al., 2016).”
BackgroundInsulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma
Dugnani, E., Balzano, G., Pasquale, V., Scavini, M., Aleotti, F., Liberati, D., Terlizzi, G. D., Gandolfi, A., Petrella, G., Reni, M., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0893-6 · Cited by 34
Association between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 33
FinDM database on diabetes in Finland
Arffman, M., Ilanne‐Parikka, P., Keskimäki, I., Kurkela, O., Lindström, J., Sund, R., & Winell, K. (2020) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 31
Self-citationSalimi, M., Broumand, B., & Mozdarani, H. (2016) · Mutagenesis · doi:10.1093/mutage/gew029 · Cited by 30
Epidemiology of Prostate Cancer in Europe: Patterns, Trends and Determinants
Bray, F., & Kiemeney, L. A. L. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-42769-0_1 · Cited by 30
Jeong, H.-S., Lee, D.-H., Kim, S., Lee, C., Shin, H. M., Kim, H., & Cho, C. (2022) · Oncogene · doi:10.1038/s41388-022-02207-y · Cited by 29
Pancreatic Cancer: A Review of Risk Factors
Grigorescu, R. R., Husar-Sburlan, I. A., & Gheorghe, C. (2024) · Life · doi:10.3390/life14080980 · Cited by 29
“Most cases of CP are triggered by the variable combination of environmental factors such as alcohol and nicotine consumption [213] and some genetic mutations in the PRSS1 Gene, SPINK 1, and CTFR genes [214,215].”
Menini, S., Iacobini, C., de Latouliere, L., Manni, I., Vitale, M., Pilozzi, E., Pesce, C. M., Cappello, P., Novelli, F., Piaggio, G., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01665-0 · Cited by 28
Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes
Zhong, W., & Mao, Y. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2960 · Cited by 28
Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin
Matza‐Porges, S., & Shamriz, O. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac089 · Cited by 29
Deleskog, A., den Hoed, M., Tettamanti, G., Carlsson, S., Ljung, R., Feychting, M., & Brooke, H. L. (2017) · Clinical Epidemiology · doi:10.2147/clep.s147188 · Cited by 27
Self-citationHormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
Losada-García, A., Cortés-Ramírez, S. A., Cruz-Burgos, M., Morales-Pacheco, M., Cruz-Hernández, C. D., González-Covarrubias, V., Pérez‐Plasencia, C., Cerbón, M. A., & Rodríguez‐Dorantes, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.673180 · Cited by 29
“Numerous meta-analyses and studies have established a link between type 1 diabetes and Pca, and a reduced risk of prostate cancer has been demonstrated, with a 44 percent lower incidence than the general population (Carstensen et al., 2016).”
BackgroundReinholdt, K., Thomsen, L. T., Munk, C., Dehlendorff, C., Aalborg, G. L., Carstensen, B., Jørgensen, M. E., & Kjær, S. K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33365 · Cited by 26
“Previous population-based cohort studies of cervical cancer risk in women with T1D have shown inconsistent results, as risk estimates have ranged from 35% lower to 60% higher than the general population.(15,17,18,21,26) In contrast, women with T2D have consistently shown an increased risk of cervical cancer.”
ResultSelf-citationSwolin‐Eide, D., Forsander, G., Lyckå, A. P., Novák, D., Grillari, J., Diendorfer, A. B., Hackl, M., & Magnusson, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-38615-7 · Cited by 26
Nair‐Shalliker, V., Bang, A., Weber, M. F., Goldsbury, D. E., Caruana, M., Emery, J. D., Banks, E., Canfell, K., O’Connell, D. L., & Smith, D. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-22589-y · Cited by 26
Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer
Gajeton, J., Krukovets, I., Muppala, S., Verbovetskiy, D., Zhang, J., & Stenina‐Adognravi, O. (2021) · Cancers · doi:10.3390/cancers13061346 · Cited by 26
Insulin and the insulin receptor collaborate to promote human gastric cancer
Saisana, M., Griffin, S. M., & May, F. E. B. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01236-y · Cited by 25
“Treatment of type II diabetes with metformin, which lowers insulin secretion [14], reduces gastric cancer incidence [15, 16] Type I diabetics have also increased gastric cancer incidence [17, 18], that reaches 3.”
BackgroundZhan, Z., Liu, L., Cheng, M., Gao, Y., & Zhou, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/2651790 · Cited by 25
Maternal diabetes and risk of childhood cancer in the offspring
Seppälä, L. K., Vettenranta, K. K., Pitkäniemi, J. M., Hirvonen, E. M., Leinonen, M. K., & Madanat‐Harjuoja, L. M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32757 · Cited by 24
Ruze, R., Chen, Y., Xu, R., Song, J., Yin, X., Wang, C., & Xu, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188844 · Cited by 23
Overweight and Obesity in Adults with Type 1 Diabetes: A Growing Challenge
Majanović, S. K., Detel, D., Igrec, M., Bergoč, A., Rahelić, V., & Rahelić, D. (2024) · Diabetology · doi:10.3390/diabetology5030018 · Cited by 23
“Additionally, a study conducted on 9000 cancers in patients with T1D showed a 17% higher risk in women and a 15% higher risk in men with T1D [16,17].”
BackgroundYan, P., Wang, Y., Fu, T., Liu, Y., & Zhang, Z.-J. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0138 · Cited by 22
Aging and cancer: Is glucose a mediator between them?
Golubev, A. G., & Anisimov, V. N. (2019) · Oncotarget · doi:10.18632/oncotarget.27344 · Cited by 22
Yang, L., Chu, T. K., Lian, J., Lo, C. W., Zhao, S., He, D., Qin, J., & Liang, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035308 · Cited by 21
Mao, D., Lau, E. S. H., Wu, H., Yang, A., Fan, B., Shi, M., Tam, C. H. T., Chow, E., Kong, A. P. S., Ronald, C. W., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1891 · Cited by 21
“1358 Most of the reports on risk association between diabetes and liver cancer came from population- based cohorts. Compared to people without diabetes, diabetes was associated with liver cancer with HRs of 1.54 and 1.78 in Korean(7) and Chinese populations, respectively.(2224) In these studies, a single plasma glucos…”
BackgroundInfluentialBeckmann, K., Russell, B. A., Josephs, D. H., Garmo, H., Häggström, C., Holmberg, L., Stattin, P. E., Hemelrijck, M. V., & Adolfsson, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5846-3 · Cited by 21
Sapoor, S., Nageh, M., Shalma, N. M., Sharaf, R. S., Haroun, N., Salama, E., Umar, T. P., Sharma, S., & Sayad, R. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002036 · Cited by 20
“T2DM accounts for 80 – 90% of PC occurrences and is the primary driver of pancreatic cancer [9] .”
BackgroundHsueh, H., Pita-Grisanti, V., Gumpper, K., Lahooti, A., Chavez-Tomar, M., Schadler, K., & Cruz‐Monserrate, Z. (2021) · Pancreatology · doi:10.1016/j.pan.2021.10.004 · Cited by 20
CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases
Ruiz-Pablos, M. (2022) · Pathogens · doi:10.3390/pathogens11080831 · Cited by 20
Richardson, B., Khan, M. Q., Brown, S. A., Watt, K. D. S., & Izzy, M. J. (2021) · Hepatology Communications · doi:10.1002/hep4.1876 · Cited by 19
Yue, C., Zhang, C., Ying, C., & Jiang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.993785 · Cited by 18
Swerdlow, A. J., Jones, M. E., Slater, S. D., Burden, A. C., Botha, J. L., Waugh, N. R., Morris, A. D., Gatling, W., Gillespie, K. M., Patterson, C., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34548 · Cited by 17
“Proxy measures have been used to categorise diabetes type, for instance by including as type 1 all patients with diabetes incident under age 40 or 50 irrespective of treatment type.(8,12) However, most patients with diabetes incident at ages 30 and above are actually type 2,(14-16) and hence cancer risks in several pu…”
MethodBril, F., & Elbert, A. E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156066 · Cited by 17
van den Brandt, P. A. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01100-0 · Cited by 16
Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
Drab, A., Wdowiak, K., Kanadys, W. M., Zajączkowski, K., Koczkodaj, P., Religioni, U., Borowska, M. W., Bogdan, M., & Lozano‐Lorca, M. (2024) · Cancers · doi:10.3390/cancers16234010 · Cited by 16
“Thus, type 1 diabetes has been linked to an increased risk of cancers of the liver, pancreas, kidneys, esophagus, stomach, lungs, and thyroid, as well as squamous cell carcinoma and leukemia [33–36].”
Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies
Ray, A. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i12.483 · Cited by 17
Type I Interferons as Joint Regulators of Tumor Growth and Obesity
Gessani, S., & Belardelli, F. (2021) · Cancers · doi:10.3390/cancers13020196 · Cited by 16
Perrier, Q., Jambon-Barbara, C., Kessler, L., Villard, O., Buron, F., Guerci, B., Borot, S., Roustit, M., Berishvilli, E., Rakotoarisoa, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0059 · Cited by 15
Guo, J., Yang, J., Wang, J., Liu, W., Kang, Y., Li, Z., Hao, C., & Qi, S. (2024) · International Journal of COPD · doi:10.2147/copd.s473089 · Cited by 15
Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
Maier, J. A. M., Castiglioni, S., Petrelli, A., Cannatelli, R., Ferretti, F., Pellegrino, G., Sarzi‐Puttini, P., Fiorina, P., & Ardizzone, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1436581 · Cited by 15
Autoimmune conditions and pancreatic cancer risk in older American adults
Yuan, F., Pfeiffer, R. M., Julián‐Serrano, S., Arjani, S., Barrett, M. J., Koshiol, J. E., & Stolzenberg‐Solomon, R. Z. (2022) · International Journal of Cancer · doi:10.1002/ijc.34235 · Cited by 15
“We hypothesize that autoimmune conditions are associated with the risk of PC.”
BackgroundMethodInfluentialNeuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer
Vasquez, J. H., & Borniger, J. C. (2020) · Endocrinology · doi:10.1210/endocr/bqaa047 · Cited by 14
Protein Disulfide Isomerases Function as the Missing Link Between Diabetes and Cancer
Jiang, H., Thapa, P., Hao, Y., Ding, N., Alshahrani, A., & Wei, Q. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0098 · Cited by 13
“A study of more than 9000 cancers in 5 countries found that T1DM contributes to increased hazard ratios for cancer of the stomach, liver, pancreas, endometrium, and kidney in both men and women (Carstensen et al, 2016).”
Co-morbidity of type 1 diabetes and endometriosis: bringing a new paradigm into focus
Simmen, R. C. M., Brown, D. M., Quick, C. M., Alhallak, I., Rose, T., Liu, S. J., & Kelley, A. S. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0248 · Cited by 13
Marcoux, S., Côté‐Corriveau, G., Healy‐Profitós, J., & Auger, N. (2022) · Diabetes Care · doi:10.2337/dc21-2107 · Cited by 13
Wu, R., Zhang, J., Zou, G., Li, S., Wang, J., Li, X., & Xu, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s450321 · Cited by 11
“17 Furthermore, research has demonstrated that patients with diabetes not only have an increased risk of thyroid cancer but are also more likely to have lymph node and distant metastasis, which may lead to worse prognoses.”
Background
Metadata
- Authors
- on behalf of the Diabetes and Cancer Research Consortium, Carstensen, B., Read, S. H., Friis, S., Sund, R., Keskimäki, I., Svensson, A.-M., Ljung, R., Wild, S. H., Kerssens, J. J., Harding, J. L., Magliano, D. J., & Gudbjörnsdottir, S.
- Affiliations
- University of Edinburgh (GB)
- Danish Cancer Society (DK)
- University of Helsinki (FI)
- Finnish Institute for Health and Welfare (FI)
- Karolinska Institutet (SE)
- National Health Service Scotland (GB)
- Baker Heart and Diabetes Institute (AU)
- Corresponding author
- Read, Stephanie H
- ORCID
- Venue
- Diabetologia
- Published
- 2016-02-29
- Volume
- 59
- Issue
- 5
- Pages
- 980-988
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC4826427
- OpenAlex
- W2288987572
- Cited by
- 180
- References
- 35
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 28 · 2021: 20 · 2020: 17 · 2019: 12 · 2018: 8 · 2017: 12 · 2016: 6
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Foundation for the Study of Diabetes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- type 1 diabetes, cancer incidence, cancer risk, sex differences, gastric cancer, liver cancer, pancreatic cancer, endometrial cancer, kidney cancer, prostate cancer, site-specific cancer risk, diabetes registry, cancer registry, hazard ratio, age at cancer diagnosis, Australia, Denmark, Finland, Scotland, Sweden, United Kingdom
- MeSH terms
- Australia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Finland, Humans, Male, Neoplasms, Risk Factors, Scotland, Sweden, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.